Reaction
White Coat Hypertension reporting signals
As of the last recalculation, White Coat Hypertension appears in 534 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is INFLIXIMAB-DYYB (PRR 100.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Infliximab-Dyyb | 66 | 100.3 | 100.5 |
| Hydrocortisone Sodium Succinate | 12 | 50.9 | 50.9 |
| Terazosin Hydrochloride | 10 | 44.6 | 44.7 |
| Niraparib | 23 | 42.2 | 42.2 |
| Octreotide Acetate | 28 | 37.5 | 37.6 |
| Lanreotide Acetate | 6 | 30.2 | 30.2 |
| Methadone Hydrochloride | 5 | 18.2 | 18.2 |
| Sodium Oxybate | 27 | 16.8 | 16.8 |